Your Chronological Age Is Fixed. Your Biological Age Is Not.

What Is Inflammaging and Biological Age?

In 2000, researcher Claudio Franceschi coined the term inflammaging to describe the chronic, low-grade systemic inflammation that builds progressively with age and drives the biology of getting older. It is not simply a consequence of time passing. It is the consequence of cumulative inflammatory burden from processed food, poor sleep, chronic stress, gut dysbiosis, sedentary behavior, and environmental toxin exposure, all of which are modifiable.

Biological age is measured through epigenetic clocks, algorithms that read DNA methylation patterns at thousands of sites across the genome and calculate how old cells actually are biologically, not chronologically. Two people with the same birthday can have biological ages that differ by decades, depending on their inflammatory burden and lifestyle. Published research consistently shows biological age predicts all-cause mortality better than chronological age and responds meaningfully to targeted intervention.

The specific mechanisms driving accelerated biological aging are well characterized: accumulation of senescent cells that release inflammatory SASP cytokines even in small numbers; NAD+ depletion falling approximately 50% between ages 20 and 60 and impairing sirtuin longevity enzymes, DNA repair, and mitochondrial function; telomere shortening with each cell division and each oxidative insult; and chronic imbalance between AMPK-driven cellular repair and mTOR-driven growth signaling that suppresses the cleanup programs maintaining cellular health.

Who the Longevity and Anti-Aging Protocol Is For

This protocol is built for patients who are dealing with one or more of the following:

• Interest in measurable biological age assessment and a structured plan to address accelerated aging markers
• Fatigue, cognitive decline, reduced recovery, or other symptoms of accelerated biological aging
• Elevated inflammatory markers, metabolic dysfunction, or other measurable indicators of increased aging burden
• A desire to preserve functional capacity, cognitive health, and physical resilience over the next decade and beyond

How the Longevity and Anti-Aging Protocol Works

The baseline panel for this protocol includes inflammatory markers (hs-CRP, IL-6), Vitamin D, NAD+ status, metabolic markers, fasting insulin, lipid panel, homocysteine, and where available, biological age testing through epigenetic clock analysis. The protocol moves through three stages targeting every identified driver of accelerated biological aging simultaneously.

What the Protocol May Include: omega-3 fatty acids at therapeutic dose to produce the D-series and E-series resolvins that terminate the inflammaging cycle; quercetin as the most accessible senolytic for clearing senescent cells and activating the Nrf2 antioxidant program; berberine for AMPK activation through the same mechanism as the TAME trial drug metformin; NMN for NAD+ restoration and sirtuin longevity enzyme function; and fisetin, pulsed two consecutive days per month, as the most accessible dedicated senolytic with human trial evidence. As the protocol advances, injectable vitamins at the clinic deliver NAD IV for direct sirtuin enzyme cofactor restoration, alpha lipoic acid crossing the blood-brain barrier for both lipid and aqueous cellular compartment antioxidant protection, CoQ10 for mitochondrial electron transport chain support, and injectable Vitamin D, which consistently tracks with faster biological aging when deficient. Stage 3 adds peptide therapy including Epithalon, which specifically stimulates telomerase to rebuild telomere length; MOTS-c for mitochondrial AMPK activation and metabolic resilience; CJC-1295/Ipamorelin or Sermorelin for the nocturnal GH pulse driving cellular repair and immune renewal that decline with age; and where clinically appropriate, low-dose rapamycin once weekly for mTOR inhibition with compelling longevity data.

Stage 1 (Pathway) establishes the foundational senolytic, AMPK, and NAD+ restoration layer. Stage 2 (Roadmap) adds injectable delivery at the clinic for therapeutic-level longevity support. Stage 3 (Atlas) is the complete protocol, adding the peptides and interventions targeting the deepest hallmarks of aging.